Trijardy XR 1000 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 1000 mg/1

Trijardy XR 1000 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for managing type 2 diabetes. This extended-release tablet supports blood sugar control as part of a comprehensive diabetes care plan.

Strength

1000 mg/1

Pack Size

30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0390-71)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 1000 mg/1 is designed to help manage type 2 diabetes by improving blood sugar levels. It combines three active ingredients—empagliflozin, linagliptin, and metformin hydrochloride—to support glycemic control. This medication is typically used alongside diet and exercise to maintain stable blood sugar levels over time.

Side Effects

Common effects of Trijardy XR 1000 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, particularly when first starting the medication. Some users may also experience urinary tract infections or low blood sugar, especially when combined with other diabetes treatments.

Precautions & Warnings

Trijardy XR 1000 mg/1 should be handled with care, particularly for those with kidney issues or a history of pancreatitis. It is important to follow medical guidance regarding its use, especially if you have conditions like dehydration or are undergoing surgery. Always consult a healthcare provider before starting this medication.

Avoid Interactions

Trijardy XR 1000 mg/1 may interact with certain medications, including other diabetes treatments, diuretics, and drugs that affect kidney function. Alcohol and certain supplements can also influence its effectiveness or increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Trijardy XR 1000 mg/1 is used to manage type 2 diabetes by helping to control blood sugar levels.

Trijardy XR 1000 mg/1 is an extended-release tablet taken orally, typically once daily with food.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and low blood sugar.

Trijardy XR 1000 mg/1 may interact with other diabetes medications, so it is important to consult a healthcare provider before combining treatments.

Individuals with severe kidney problems, a history of pancreatitis, or those undergoing surgery should exercise caution and consult a healthcare provider before taking Trijardy XR 1000 mg/1.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.